Covert vertical transmission of feline immunodeficiency virus

AIDS Research and Human Retroviruses

Volumn 19, Issue 5, 2003, Pages 421-434

  Allison, Robin W ^a   Hoover, Edward A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS DNA; VIRUS ENVELOPE PROTEIN;

ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CAT; CAT DISEASE; ENVELOPE GENE; FELINE IMMUNODEFICIENCY VIRUS; LYMPHOCYTE COUNT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; VERTICAL TRANSMISSION; VIRUS ISOLATION; VIRUS TRANSMISSION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; CATS; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; FEMALE; IMMUNODEFICIENCY VIRUS, FELINE; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROVIRUSES;

EID: 0037845282     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203765551764     Document Type: Article

References (80)

1. UNAIDS/WHO: AIDS Epidemic Update. Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization (WHO), Geneva, Switzerland, 2001.
2. Kuhn L, Meddows-Taylor S, Gray G, and Tiemessen C: Human immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero. Clin Infect Dis 2002;34: 267-276.
3. Li Q, Tsang B, Ding L, and Ding ZR: Vertical transmission of human immunodeficiency virus type 1: Frequency and correlation of transmission [review]. Int J Mol Med 1998;1:589-591.
4. Robb M, Bridges S, Mmiro F, Fowler M, Fast P, and McNamara J: Report of the Prevention of Perinatal HIV Type 1 Transmission Workshop: Conference summary. AIDS Res Hum Retroviruses 1995;11: 1301-1303.
5. Chouquet C, Richardson S, Burgard M, Blanche S, Mayaux MJ, Rouzioux C, et al.: Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: Bayesian estimation using a mixture. Stat Med 1999;18:815-833.
6. Kuhn L, Abrams EJ, Matheson PB, Thomas PA, Lambert G, Bamji M, et al.: Timing of maternal-infant HIV transmission: Associations between intrapartum factors and early polymerase chain reaction results. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS 1997;11:429-435.
7. Towers CV, Deveikis A, Asrat T, Major C, and Nageotte MP: A "bloodless cesarean section" and perinatal transmission of the human immunodeficiency virus. Am J Obstet Gynecol 1998;179:708-714.
8. Nourse CB and Butler KM: Perinatal transmission of HIV and diagnosis of HIV infection in infants: A review. Ir J Med Sci 1998;167: 28-32.
9. Van de Perre P: Postnatal transmission of human immunodeficiency virus type 1: The breast-feeding dilemma. Am J Obstet Gynecol 1995; 173:483-487.
10. Bobat R, Moodley D, Coutsoudis A, and Coovadia H: Breastfeeding by HIV-1-infected women and outcome in their infants: A cohort study from Durban, South Africa. AIDS 1997;11:1627-1633.
11. Dunn DT, Newell ML, Ades AE, and Peckham CS: Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992;340:585-588.
12. Courgnaud V, Laure F, Brossard A, Bignozzi C, Goudeau A, Barin F. et al.: Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses 1991;7:337-341.
13. Levy JA, Hsueh F, Blackboum DJ, Wara D, and Weintrub PS: CD8 cell noncytotoxic antiviral activity in human immunodeficiency virus-infected and -uninfected children. J Infect Dis 1998;177:470-472.
14. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al.: T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000;96:3866-3871.
15. Kuhn L, Coutsoudis A, Moodley D, Trabattoni D, Mngqundaniso N, Shearer GM, et al.: T-helper cell responses to HIV envelope peptides in cord blood: Protection against intrapartum and breast-feeding transmission. AIDS 2001; 15:1-9.
16. Kuhn L, Coutsoudis A, Moodley D, Mngqundaniso N, Trabattoni D, Shearer GM, et al.: Interferon-γ and interleukin-10 production among HIV-1-infected and uninfected infants of HIV-1-infected mothers. Pediatr Res 2001;50:412-416.
17. Cheynier R, Langlade-Demoyen P, Marescot MR, Blanche S, Blondin G, Wain-Hobson S, et al.: Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus-1-infected mothers. Eur J Immunol 1992;22:2211-2217.
18. Rowland-Jones SL, Nixon DF, Aldhous MC, Gotch F, Ariyoshi K, Hallam N, et al.: HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet 1993;341:860-861.
19. English RV, Nelson P, Johnson CM, Nasisse M, Tompkins WA, and Tompkins MB: Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis 1994;170:543-552.
20. Pedersen NC, Ho EW, Brown ML, and Yamamoto JK: Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 1987;235:790-793.
21. Pedersen NC: The feline irnmunodeficiency virus. In: The Retroviridae (Levy JA, ed.). Plenum Press, New York, 1993, pp. 181-228.
22. Yamamoto JK, Hansen H, Ho EW, Morishita TY, Okuda T, Sawa TR, et al.: Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission. J Am Vet Med Assoc 1989;194:213-220.
23. O'Neil LL, Burkhard MJ, Diehl LJ, and Hoover EA: Vertical transmission of feline immunodeficiency virus. AIDS Res Hum Retroviruses 1995;11:171-182.
24. Sellon RK, Jordan HL, Kennedy-Stoskopf S, Tompkins MB, and Tompkins WA: Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection. J Virol 1994;68:3380-3385.
25. Callanan JJ, Hosie MJ, and Jarrett O: Transmission of feline immunodeficiency virus from mother to kitten. Vet Rec 1991;128: 332-333.
26. Wasmoen T, Armiger-Luhman S, Egan C, Hall V, Chu H-J, Chavez L, et al.: Transmission of feline immunodeficiency virus from infected queens to kittens, Vet Immunol Immunopathol 1992;35: 83-93.
27. Rogers AB and Hoover EA: Maternal-fetal feline immunodeficiency virus transmission: Timing and tissue tropisms. J Infect Dis 1998; 178:960-967.
28. Rogers AB and Hoover EA: Fetal feline immunodeficiency virus is prevalent and occult. J Infect Dis 2002;186:895-904.
29. Allison RW: Perinatal Feline Immunodeficiency Virus Infection: A Model of in utero and Milk-Borne HIV-1 Transmission. Ph.D. dissertation. Department of Pathology, Colorado State University, Fort Collins, Colorado, 2002.
30. O'Neil LL, Burkhard MJ, Obert LA, and Hoover EA: Regression of feline immunodeficiency virus infection. AIDS Res Hum Retroviruses 1997;13:713-718.
31. O'Neil LL, Burkhard MJ, and Hoover EA: Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J Virol 1996;70:2894-2901.
32. Dean GA, Quackenbush SL, Ackley CD, Cooper MD, and Hoover EA: Flow cytometric analysis of T-lymphocyte subsets in cats. Vet Immunol Immunopathol 1991;28:327-335.
33. O'Reilly, Hoover EA: Characterization of a panel of monoclonal antibodies specific for subsets of feline leukocytes. In: International Symposium on Feline Retrovirus Research. North Carolina State University, Raleigh, North Carolina, 1993.
34. Dreitz MJ, Dow SW, Fiscus SA, and Hoover EA: Developmental of monoclonal antibodies and capture immunoassays for feline immunodeficiency virus. Am J Vet Res 1995;56:764-768.
35. Jehuda-Cohen T, Slade BA, Powell JD, Villinger F, De B, Folks TM, et al.: Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals. Proc Natl Acad Sci USA 1990;87:3972-3976.
36. Bachmann MH, Sodora DL, Mathiason-DuBard C, Learn GH, Rodrigo AG, Mazzetti P, et al.: Genetic diversity of feline immunodeficiency virus: Dual infection, recombination and distinct evolutionary rates between envelope sequence clades. J Virol 1997;71:4241-4253.
37. + thymic lymphocytes express reduced levels of CD8β and increased interferon T in cats perinatally infected with the JSY3 molecular clone of feline immunodeficiency virus. AIDS Res Hum Retroviruses 2000;16:1559-1571.
38. George JW, Pedersen NC, and Higgins J: The effect of age on the course of experimental feline immunodeficiency virus infection in cats. AIDS Res Hum Retroviruses 1993;9:897-905.
39. Obert LA and Hoover EA: Feline immunodeficiency virus clade C mucosal transmission and disease courses. AIDS Res Hum Retroviruses 2000;16:677-688.
40. O'Connor TP Jr, Tanguay S, Steinman R, Smith R, Barr MC, Yamamoto JK, et al.: Development and evaluation of immunoassay for detection of antibodies to the feline T-lymphotropic lentivirus (feline immunodeficiency virus). J Clin Microbiol 1989;27:474-479.
41. Yamamoto JK, Sparger E, Ho EW, Andersen PR, O'Connor TP, Mandell CP, et al.: Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am J Vet Res 1988;49:1246-1258.
42. Burkhard MJ, Mathiason CK, O'Halloran K, and Hoover EA: Kinetics of early FIV infection in cats exposed via the vaginal versus intravenous route. AIDS Res Hum Retroviruses 2002;18:217-226.
43. Dandekar S, Beebe AM, Barlough J, Phillips T, Elder J, Torten M, et al.: Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. J Virol 1992;66:4040-4049.
44. + lymphocytes. J Immunol 1988;140:2237-2242.
45. + cell anti-HIV activity: Nonlytic suppression of virus replication. AIDS Res Hum Retroviruses 1992;8:1039-1050.
46. + antiviral activity in cats infected with feline immunodeficiency virus. J Virol 1996;70:2474-2480.
47. + T cell mediated noncytolytic inhibition of human immunodeficiency virus type I. Front Biosci 2001;6:D575-D598.
48. +-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV. J Virol 1998;72:10029-10035.
49. Miller CJ, Marthas M, Torten J, Alexander NJ, Moore JP, Doncel GF, et al.: Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol 1994;68:6391-6400.
50. Sahu GK, Chen JJ, Huang JC, Ramsey KM, and Cloyd MW: Transient or occult HIV-1 infection in high-risk adults. AIDS 2001;15: 1175-1177.
51. Borkowsky W, Krasinski K, Moore T, and Papaevangelou V: Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children. AIDS Res Hum Retroviruses 1990;6:673-678.
52. Wasik TJ, Bratosiewicz J, Wierzbicki A, Whiteman VE, Rutstein RR, Starr SE, et al.: Protective role of β-chemokines associated with HIV-specific Th responses against perinatal HIV transmission. J Immunol 1999;162:4355-4364.
53. Aldhous MC, Watret KC, Mok JY, Bird AG, and Froebel KS: Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol 1994;97:61-67.
54. McFarland EJ, Harding PA, Luckey D, Conway B, Young RK, and Kuritzkes DR: High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection. J Infect Dis 1994; 170:766-774.
55. Luzuriaga K, Holmes D, Hereema A, Wong J, Panicali DL, and Sullivan JL: HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J Immunol 1995;154:433-443.
56. Newell ML, Dunn D, De Maria A, Ferrazin A, De Rossi A, Giaquinto C, et al.: Detection of vires in vertically exposed HIV-antibody-negative children. Lancet 1996;347:213-215.
57. Roques PA, Gras G, Parnet-Mathieu F, Mabondzo AM, Dollfus C, Narwa R, et al.: Clearance of HIV infection in 12 perinatally infected children: Clinical, virological and immunological data. AIDS 1995;9: F19-F26.
58. Frenkel LM, Mullins JI, Learn GH, Manns-Arcuino L, Herring BL, Kalish ML, et al.: Genetic evaluation of suspected cases of transient HIV-1 infection of infants. Science 1998;280:1073-1077.
59. Bryson YJ, Pang S, Wei LS, Dickover R, Diagne A, and Chen IS: Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995;332:833-838.
60. + cell noncytotoxic anti-HIV response. Proc Natl Acad Sci USA 1999;96:1030-1035.
61. Kaul R, Rowland-Jones SL, Kimani J, Fowke K, Dong T, Kiama P, et al.: New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. Immunol Lett 2001;79:3-13.
62. + lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 2000;164: 1602-1611.
63. Butera ST, Pisell TL, Limpakarnjanarat K, Young NL, Hodge TW, Mastro TD, et al.: Production of a novel viral suppressive activity associated with resistance to infection among female sex workers exposed to HIV type 1. AIDS Res Hum Retroviruses 2001;17: 735-744.
64. Bernard NF, Yannakis CM, Lee JS, and Tsoukas CM: Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons. J Infect Dis 1999;179: 538-547.
65. Miller CJ, McChesney MB, Lu X, Dailey PJ, Chutkowski C, Lu D, et al.: Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol 1997;71:1911-1921.
66. Lifson JD, Rossio JL, Arnaout R, Li L, Parks TL, Schneider DK, et al.: Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment. J Virol 2000;74: 2584-2593.
67. Clerici M, Clark EA, Polacino P, Axberg I, Kuller L, Casey NI, et al.: T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 1994;8:1391-1395.
68. Zhou L, Yoshimura Y, Huang Y, Suzuki R, Yokoyama M, Okabe M, et al.: Two independent pathways of maternal cell transmission to offspring: Through placenta during pregnancy and by breast-feeding after birth. Immunology 2000;101:570-580.
69. Shimamura M, Ohta S, Suzuki R, and Yamazaki K: Transmission of maternal blood cells to the fetus during pregnancy: Detection in mouse neonatal spleen by immunofluorescence flow cytometry and polymerase chain reaction. Blood 1994;83:926-930.
70. Petit T, Dommergues M, Socie G, Dumez Y, Gluckman E, and Brison O: Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification. Br J Haematol 1997;98:767-771.
71. Lo YM, Lo ES, Watson N, Noakes L, Sargent IL, Thilaganathan B, et al.: Two-way cell traffic between mother and fetus: Biologic and clinical implications. Blood 1996;88:4390-4395.
72. Lo YM, Lau TK, Chan LY, Leung TN, and Chang AM: Quantitative analysis of the bidirectional fetomaternal transfer of nucleated cells and plasma DNA. Clin Chem 2000;46:1301-1309.
73. Hall JM, Lingenfelter P, Adams SL, Lasser D, Hansen JA, and Bean MA: Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood 1995;86:2829-2832.
74. Maloney S, Smith A, Furst DE, Myerson D, Rupert K, Evans PC, et al.: Microchimerism of maternal origin persists into adult life. J Clin Invest 1999;104:41-47.
75. Claas FH, Gijbels Y, van der Velden-de Munck J, and van Rood JJ: Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science 1988;241:1815-1817.
76. Hadley GA, Phelan D, Duffy BF, and Mohanakumar T: Lack of T-cell tolerance of noninherited maternal HLA antigens in normal humans. Hum Immunol 1990;28:373-381.
77. Roelen DL, van Bree FP, van Beelen E, van Rood JJ, and Claas FH: No evidence of an influence of the noninherited maternal HLA antigens on the alloreactive T cell repertoire in healthy individuals. Transplantation 1995;59:1728-1733.
78. Burlingham WJ, Grailer AP, Heisey DM, Claas FH, Norman D, Mohanakumar T, et al.: The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 1998;339:1657-1664.
79. Olding LB and Oldstone BA: Thymus-derived peripheral lymphocytes from human newborns inhibit division of their mothers' lymphocytes. J Immunol 1976;116:682-686.
80. Berry RM and Nowak MA: Defective escape mutants of HIV. J Theor Biol 1994;171:387-395.